Losartan protects liver against ischaemia/reperfusion injury through <scp>PPAR</scp>‐<scp>γ</scp> activation and receptor for advanced glycation end‐products down‐regulation

Abstract

Our findings suggest that losartan ameliorates I/R-induced liver damage through PPAR-γ activation and down-regulation of the RAGE signalling pathway.